Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

IKZF1 deletions predict a poor prognosis in children with B-cell progenitor acute lymphoblastic leukemia: a multicenter analysis in Taiwan.

Yang YL, Hung CC, Chen JS, Lin KH, Jou ST, Hsiao CC, Sheen JM, Cheng CN, Wu KH, Lin SR, Yu SL, Chen HY, Lu MY, Wang SC, Chang HH, Lin SW, Su YN, Lin DT.

Cancer Sci. 2011 Oct;102(10):1874-81. doi: 10.1111/j.1349-7006.2011.02031.x. Epub 2011 Aug 12.

2.

IKAROS Gene Deleted B-Cell Acute Lymphoblastic Leukemia in Mexican Mestizos: Observations in Seven Patients and a Short Review of the Literature.

Ruiz-Delgado GJ, Cantero-Fortiz Y, León-Peña AA, León-González M, Nuñez-Cortés AK, Ruiz-Argüelles GJ.

Rev Invest Clin. 2016 Jul-Aug;68(4):210-4. Review.

3.

How new advances in genetic analysis are influencing the understanding and treatment of childhood acute leukemia.

Roberts KG, Mullighan CG.

Curr Opin Pediatr. 2011 Feb;23(1):34-40. doi: 10.1097/MOP.0b013e3283426260. Review.

PMID:
21169835
4.

Ikaros and leukaemia.

Olsson L, Johansson B.

Br J Haematol. 2015 May;169(4):479-91. doi: 10.1111/bjh.13342. Epub 2015 Mar 5. Review.

PMID:
25753742
5.

The clinical relevance of chromosomal and genomic abnormalities in B-cell precursor acute lymphoblastic leukaemia.

Moorman AV.

Blood Rev. 2012 May;26(3):123-35. doi: 10.1016/j.blre.2012.01.001. Epub 2012 Mar 20. Review.

PMID:
22436535
6.

Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy.

Tzortzatou-Stathopoulou F, Papadopoulou AL, Moschovi M, Botsonis A, Tsangaris GT.

J Pediatr Hematol Oncol. 2001 Dec;23(9):591-7. Review.

PMID:
11902303
7.

Genomic profiling of high-risk acute lymphoblastic leukemia.

Collins-Underwood JR, Mullighan CG.

Leukemia. 2010 Oct;24(10):1676-85. doi: 10.1038/leu.2010.177. Epub 2010 Aug 26. Review.

PMID:
20739952
8.

Detection of residual disease in pediatric B-cell precursor acute lymphoblastic leukemia by comparative phenotype mapping: method and significance.

Dworzak MN, Fritsch G, Panzer-Grümayer ER, Mann G, Gadner H.

Leuk Lymphoma. 2000 Jul;38(3-4):295-308. Review.

PMID:
10830736
9.

Pathogenesis and regulation of cellular proliferation in acute lymphoblastic leukemia - the role of Ikaros.

Wang H, Ouyang H, Lai L, Petrovic-Dovat L, Stankov K, Bogdanovic G, Dovat S.

J BUON. 2014 Jan-Mar;19(1):22-8. Review.

PMID:
24659638
10.

Ikaros: Exploiting and targeting the hematopoietic stem cell niche in B-progenitor acute lymphoblastic leukemia.

Churchman ML, Mullighan CG.

Exp Hematol. 2017 Feb;46:1-8. doi: 10.1016/j.exphem.2016.11.002. Epub 2016 Nov 16. Review.

11.

Ikaros and tumor suppression in acute lymphoblastic leukemia.

Payne KJ, Dovat S.

Crit Rev Oncog. 2011;16(1-2):3-12. Review.

12.

Genetic abnormalities associated with acute lymphoblastic leukemia.

Yokota T, Kanakura Y.

Cancer Sci. 2016 Jun;107(6):721-5. doi: 10.1111/cas.12927. Epub 2016 Apr 27. Review.

13.

The many faces of IKZF1 in B-cell precursor acute lymphoblastic leukemia.

Marke R, van Leeuwen FN, Scheijen B.

Haematologica. 2018 Apr;103(4):565-574. doi: 10.3324/haematol.2017.185603. Epub 2018 Mar 8. Review.

14.

IKZF1: a critical role in the pathogenesis of systemic lupus erythematosus?

Hu SJ, Wen LL, Hu X, Yin XY, Cui Y, Yang S, Zhang XJ.

Mod Rheumatol. 2013 Mar;23(2):205-9. doi: 10.1007/s10165-012-0706-x. Epub 2012 Jul 11. Review.

PMID:
22782532
15.

[Correlation of IKZF1 Gene with Malignant Tumors and Systemic Lupus Erythematosus].

Wen Q, Wu MR, He YZ, Li YH.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2015 Apr;23(2):591-5. doi: 10.7534/j.issn.1009-2137.2015.02.058. Review. Chinese.

PMID:
25948231

Supplemental Content

Support Center